R&D Partner Content 9th Microbiome Movement Summit Europe Translating Microbiome R&D into Improved Healthcare Outcomes & Commercial Potential
Partner Content Partner Content Exclusive Interview with Martin Everett, CSO, Antabio, speak... Exclusive Interview with Martin Everett
Partner Content Partner Content SMi’s Pharma Microbiology in Boston 2-day event what to expe... SMi’s Pharmaceutical Microbiology in Boston
Partner Content Partner Content Invite from Lynne Ensor chair for Pharma Microbiology East C... Invite from Lynne Ensor chair for Pharma Microbiology
Partner Content Partner Content Registration Opens for SMi’s 3rd Annual Pharmaceutical Micro... Registration Opens SMi’s Pharma Microbiology Boston
Partner Content Partner Content Top decision makers to present at SMi’s 9th Annual Pharma Mi... Top decision makers to present at Pharma Microbiology
News Just how radical is the FDA's complete response letter move? The FDA says publishing complete response letters for medicines is an act of "radical transparency," but it is not as revolutionary as it seems.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
